GTGuluzar Arzu Turan

Guluzar Arzu Turan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guluzar Arzu Turan has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Leslie Appiah

    Department of Obstetrics and Gynecology, Division of Academic Specialists in Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, USA

    2 shared publications
  • Bulent Tolga Delibasi

    Long School of Medicine, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA

    1 shared publication
  • Cassandra Roeca

    Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Colorado Anschutz Medical Campus, Aurora, USA

    1 shared publication
  • Dana Siegel

    Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Colorado Anschutz Medical Campus, Aurora, USA

    1 shared publication
  • Elena Shagisultanova

    Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, USA

    1 shared publication
  • Emma Greenberg

    University of Colorado School of Medicine, Aurora, CO, USA

    1 shared publication

Latest Publications

  • Open Access

    Gestational Diabetes and Genetics: MTNR1B, CDKAL1, and IRS1 as Critical Players

    by Guluzar Arzu Turan, Nehir Aran, Bulent Tolga Delibasi

    Gestational diabetes mellitus (GDM) is a prevalent pregnancy complication with significant short- and long-term consequences for mothers and offspring. While environmental factors, such as obesity and diet, contribute to the risk, genetic predisposition also plays a role in the pathogenesis of GDM. Genome-wide association studies have identified multiple susceptibility loci, including MTNR1B, CDKAL1, and IRS1, which represent mechanistically distinct pathways affecting β-cell function, insulin secretion, and peripheral insulin signaling. This review provides a unified mechanistic framework explaining why these three genes, despite individually modest effect sizes, offer complementary insights into GDM pathophysiology that extend beyond other established loci such as TCF7L2. We critically evaluate the current evidence for genetic risk scores in GDM prediction, acknowledging that their incremental predictive value beyond traditional clinical factors remains modest AUC improvement typically <0.05). The integration of genetic variants with epigenetic modifications is discussed, with careful attention to distinguishing causal mechanisms from correlative findings. We emphasize significant limitations in current research, including population stratification, winner’s curse effects, and the predominance of East Asian cohorts. While genetic insights may eventually inform risk stratification, substantial barriers remain before clinical implementation, including insufficient predictive accuracy, lack of cost-effectiveness data, and limited generalizability across diverse populations. Future directions include integrating multi-omics data, developing ethnically validated polygenic risk scores, and conducting pragmatic randomized controlled trials to establish the clinical utility of precision prevention strategies.


  • Preserving Fertility in Breast Cancer Care: Options and Considerations

    by Dana Siegel, Madeline Higgins, Cassandra Roeca, Sarah Tevis, Guluzar Arzu Turan, Elena Shagisultanova, Leslie Appiah

  • The effects of cancer treatments on uterine function

    by Emma Greenberg, Katya Strage, Noelle Ozimek, Kamilah Abdur-Rashid, Guluzar Turan, Sarah Milgrom, Leslie Appiah